This page shows the latest ASH news and features for those working in and with pharma, biotech and healthcare.
At the 63rd ASH Annual Meeting, bluebird bio revealed new data demonstrating that adult and paediatric patients diagnosed with β-thalassaemia, who require regular RBC transfusions, can produce normal or
Roche will present a slew of new data at the American Society of Hematology’s (ASH) annual meeting next month, showcasing new immunotherapies, treatment combinations, novel endpoints and fixed-duration regimens ... Our data at ASH reinforces our
A round-up of some of the key data from the annual American Society of Hematology (ASH) meeting. ... bluebird bio also posted long-term data for its own beta thalassaemia gene therapy Zynteglo (betibeglogene autotemcel) at ASH 2020.
Results presented at annual American Society of Haematology (ASH) meeting. bluebird bio has revealed some long-term data for its gene therapy betibeglogene autotemcel, which is marketed as Zynteglo in the ... bluebird bio announced the new long-term data
CML). The detailed results, presented at the annual American Society of Hematology (ASH) meeting, come from the phase 3 ASCEMBL study.
Magrolimab (formerly Hu5F9-G4) generated positive results in a phase 1b study reported at the ASH conference in the US in December, which revealed a 92% overall response rate – including 50%
More from news
Approximately 13 fully matching, plus 69 partially matching documents found.
By Ash Rishi. The world changed in 2020. I don’t need to explain how. ... Ash Rishi is CEO and Co-Founder of COUCH Health. 29th June 2022.
observed Ash Rishi, co-founder of creative health engagement agency COUCH Health.
It is a promising start but Ash Rishi, co-founder of patient engagement agency COUCH Health, witnesses a consistent lack of diversity across ethnicity, gender, age and socio-economic status in
By Ash Rishi. The healthcare industry has work to do. There is a known implicit bias in healthcare, which has been shown to influence treatment decisions, adherence and patient health outcomes. ... Ash Rishi is CEO and Co-Founder of COUCH Health.
By Yvonne Ash. No company could have planned for the impact of coronavirus on safeguarding employees while ensuring business continuity and the need to adapt to a virtual environment.We have ... Yvonne Ash is Vice President, Learning Solutions at Syneos
More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.
We’re thrilled to welcome Mark to COUCH Health. I’ve always been inspired by his energy and enthusiasm for everything that he works on,” commented Ash Rishi, chief executive officer
Ash Kuchel, global group president of Publicis Health, said: “With her infectious passion and vision, Victoria was the perfect person for the job.
Ash Rishi, COUCH's managing director, said: “We are proud to welcome Jenny to our team and excited to introduce her to our range of healthcare accounts.
Ash Rishi, also co-managing director at Couch, said: “The fact that they both have industry experience is a huge plus, but their experience of working with big brands such as
More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.
various degrees of ash and smoke for most of July and August.
If you’re interested in getting involved in our mission to Demand Diversity, get in touch at ash@demanddiversity.co.
Mark will report directly to CEO Ash Rishi. “It has been exciting to watch COUCH Health mature in recent years and firmly establish itself in the industry. ... COUCH Health CEO Ash Rishi added: “We’re thrilled to welcome Mark to COUCH Health.
W ithout attracting diverse participant groups in clinical studies, we can’t be confident about how new treatments will work in the general population,” said CEO Ash Rishi. ... As our research shows, the barriers stopping ethnic minorities from
But going back to “what would mandatory look like?”, Ash believes we should have diversity benchmarks per disease area. ... Ash agreed with this approach, explaining that the engagement model in clinical trials is evolving.
More from PMHub
Approximately 2 fully matching, plus 16 partially matching documents found.
Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...